Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Congress moves to punish Medtronic and other 'corporate deserters'
Mass Device
Tuesday, August 5, 2014 - 1:42pm
tags:
tax inversions, medronic, devices, device tax
Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook
Yahoo/Zacks.com
Tuesday, August 5, 2014 - 1:22pm
tags:
earnings, Actavis
Note to Big Pharma: Discounts work. GSK price cuts score Advair a payer boost
Fierce Pharma
Tuesday, August 5, 2014 - 11:40am
tags:
GSK, Advair, drug discounts
Allergan Being ’Obstructive’ in Deal Defense, Firm Says
Bloomberg
Tuesday, August 5, 2014 - 11:32am
tags:
Allergan, Valeant Pharmaceuticals, M&A
The Positives and Negatives of Pfizer's $635 purchase of Baxter's Vaccines
Yahoo/Benzinga
Tuesday, August 5, 2014 - 11:25am
tags:
Pfizer, vaccines, M&A, Baxter International
Have Faster FDA Drug Approvals Caused More Safety Problems?
WSJ Online
Tuesday, August 5, 2014 - 10:24am
tags:
FDA, drug approvals
Allergan Comments on Valeant’s Second Quarter 2014 Earnings Results
Yahoo
Tuesday, August 5, 2014 - 10:11am
tags:
Allergan, Valeant Pharmaceuticals, earnings, M&A
Regeneron sales top forecast as Eylea picks up steam
Yahoo/Reuters
Tuesday, August 5, 2014 - 10:01am
tags:
earnings, Eylea, Regeneron
Pfizer Megadeal Still in Sight After Astra: Real M&A
Bloomberg
Tuesday, August 5, 2014 - 9:06am
tags:
Pfizer, AstraZeneca, M&A, GSK, Actavis
Juno Therapeutics Has Raised $300 Million In Just 12 Months
Forbes
Tuesday, August 5, 2014 - 9:04am
tags:
Juno Therapeutics, CARTs
Ebola Drug Provided for Two Americans by Nine-Employee Company
Yahoo/Bloomberg
Tuesday, August 5, 2014 - 8:47am
tags:
ebola virus, Mapp Biopharmaceutical, ZMapp
Sarepta Ready to Provide Ebola Drug if Needed
Barron's
Tuesday, August 5, 2014 - 8:05am
tags:
Sarepta Therapeutics, ebola virus
Novo Nordisk Leapfrogs Glaxo as U.K. Drug Giant Declines
Bloomberg
Tuesday, August 5, 2014 - 8:01am
tags:
Novo Nordisk, GSK, insulin, diabetes
Merck Completes Tender Offer to Acquire Idenix
Yahoo
Tuesday, August 5, 2014 - 7:58am
tags:
Merck, Idenix, M&A
Most popular news headlines for Monday, August 4 2014
CP Wire
Monday, August 4, 2014 - 11:20pm
tags:
ebola virus, TKM-EBOLA, Bristol-Myers Squibb, GSK, Sanofi, Advair, nivolumab
Dealpolitik: Allergan Throws Complex Road Block at Valeant, Pershing Square
WSJ Online
Monday, August 4, 2014 - 4:23pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Biotech IPO's: Does the First Day's Trading Matter?
Forbes
Monday, August 4, 2014 - 2:56pm
tags:
biotech, IPOs
ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance
Yahoo/Zacks.com
Monday, August 4, 2014 - 2:53pm
tags:
Immunogen, earnings
FirstWord Lists: Pharma's biggest pipeline drugs
First Word Pharma
Monday, August 4, 2014 - 11:53am
tags:
pipelines, nivolumab, Pembrolizumab, evolocumab, palbociclib, cancer, breast cancer, Pfizer, Bristol-Myers Squibb, Merck, Amgen
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
Wall St Transcript
Monday, August 4, 2014 - 11:46am
tags:
Roche, Santaris, M&A, RNA-targeted medicines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.